Step 1: Registering your interest with SPCR online

First, we will need you to complete one of our online questionnaires on our website. This allows our team to learn more about you and your condition.

You can also do this over the phone, with a member of our Patient Engagement Team.

We’ll usually ask you about your medical history, current medications and treatments, questions about your illness, how it started and any upcoming procedures.

Step 2: Patient Information Visit (PIV)

A member of the team will contact you after you are matched to one of our studies, and you’ll be invited to the clinic for a PIV.

The PIV is a two-way information session.

During the PIV:

Here, you will meet the team and get to ask any study related questions.

The team also have the opportunity to further discuss with you your suitability for the study.

Step 2a: Screening Visit

If you are suitable following your PIV, we will book you in for a screening visit.

Here, you will sign the Informed Consent before proceeding with the study.

Step 2b – Screening Assessments

Once you have decided to participate, your screening assessments are next.

They include extensive medical tests, such as MRI’s, X-Rays, ECG’s and memory assessments.

Step 3: Randomisation Visit

Your screening assessment results will confirm your eligibility for the study.

If you are eligible, you will first receive the study drug during your Randomisation Visit, which may include additional tests to ensure your safety.

Step 4: Ongoing Clinic Visits and Treatments

You will visit our clinic once a month on average, where you’ll be given the study medication. These visits may involve follow up tests or procedures.

What is clinical research article image

Follow Up Visits and Trial Results

Once your treatment period has finished, you will have follow up phone calls and visits.

You won’t be unblinded for a while until the results from the study are ready. This is due to the fact that all data needs to be collated and analysed and it requires all participants to have finished the trial globally and most countries are set up on different time scales.